C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media

More topics under "C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media" (918,689)
C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
C12N 11 - Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof (12,439)
C12N 13 - Treatment of micro-organisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves (3,958)
C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
C12N 3 - Spore-forming or isolating processes (415)
C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)

Patents for C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media (9,992)
11/2004
11/18/2004	WO2004099375A2 Indirectly linked photosensitizer immunoconjugates, processes for the production thereof and methods of use therof
11/18/2004	WO2004099373A2 Biocompatible resists
11/18/2004	WO2004099371A2 Methods of treating ischemic related conditions
11/18/2004	WO2004099367A2 Methods for producing zinc finger proteins that bind to extended dna target sequences
11/18/2004	WO2004099366A2 Context sensitive parallel optimization of zinc finger dna binding domains
11/18/2004	WO2004099364A2 Multicellular compositions of pluripotent human embryonic stem cells and cancer cells
11/18/2004	WO2004087861A3 Biological contamination-removal method
11/18/2004	WO2004078934A8 Targeting site-2 protease (s2p) for the treatment of pancreatic cancer
11/18/2004	WO2004037997A3 Fragments and activity of rel protein in m. tuberculosis adn other uses thereof
11/18/2004	WO2003100002A3 Predicting the significance of single nucleotide polymorphisms (snps) using ensemble-based structural energetics
11/18/2004	WO2003095624A3 Liver inflammation predictive genes
11/18/2004	WO2003080805A3 Kinases and phosphatases
11/18/2004	US20040231010 Lysozyme transgenic ungulates
11/18/2004	US20040230043 Novel neurotrophic factors
11/18/2004	US20040229326 produced from host microoganism cultures and solvent extraction
11/18/2004	US20040229284 Multiplex analysis of proteins
11/18/2004	US20040229266 RNA interference mediating small RNA molecules
11/18/2004	US20040229247 Methods of metallizing nucleic acid molecules and methods of attaching nucleic acid molecules to conductive surfaces
11/18/2004	US20040229234 Determining RNA expression patterns of tissues propagated in three dimension collagen matrix; genomics; disease diagnosis and transcriptional expression patterns
11/18/2004	US20040229208 Methods for the identification of inhibitors of CAX1-like Ca+2/H+ antiporter activity in plants
11/18/2004	US20040228842 Compositions and methods for cytomegalovirus treatment
11/18/2004	US20040228836 cancer therapeutic agent comprising a cancer targeting molecule linked to a liver-expressed chemokine (LEC)
11/18/2004	US20040226819 Dielectrophoresis apparatus
11/18/2004	US20040226408 Recovery of bioleaching microbes
11/18/2004	DE10297331T5 Behandlung und Diagnose von Insulin-resistenten Zuständen Treatment and diagnosis of insulin-resistant conditions
11/18/2004	CA2525298A1 Methods of treating ischemic related conditions
11/18/2004	CA2525029A1 Use of jag2 expression in diagnosis of plasma cell disorders
11/18/2004	CA2524912A1 An autologous upregulation mechanism allowing optimized cell type-specific and regulated gene expression cells
11/18/2004	CA2524393A1 Solid phase cell lysis and capture platform
11/18/2004	CA2524261A1 Chromatographic assay system
11/17/2004	EP1476748A2 Gene function inferring using gene expression data
11/17/2004	EP1476747A2 Molecular hepatotoxicology modeling
11/17/2004	EP1476561A2 Reducing non-target nucleic acid dependent amplifications: amplifying repetitive nucleic acid sequences
11/17/2004	EP1476541A2 Novel cytokine zcytor17 ligand
11/17/2004	CN1547590A Humanized anti-LT-beta-R antibodies
11/11/2004	WO2004097005A2 Global analysis of transposable elements as molecular markers of the developmental potential of stem cells
11/11/2004	WO2004097004A2 Trasngenic expression of a phytochrome a gene
11/11/2004	WO2004097003A2 Multiply-primed amplification of nucleic acid sequences
11/11/2004	WO2004097002A2 SELECTIVE TESTICULAR 11β-HSD INHIBITORS AND METHODS OF USE THEREOF
11/11/2004	WO2004097000A2 Ligand-exchange functional antigens, and use of same in pharmaceutical vaccine compositions
11/11/2004	WO2004096999A2 In vitro translation system
11/11/2004	WO2004096998A2 Nanoparticular tumor targeting and therapy
11/11/2004	WO2004096997A2 Molecular detection systems utilizing reiterative oligonucleotide synthesis
11/11/2004	WO2004096996A2 Modulation of glucagon receptor expression
11/11/2004	WO2004096995A2 Recombinant plant dicer
11/11/2004	WO2004096994A2 Genes upregulated in a tomato plant having an increased anthocyanin content phenotype
11/11/2004	WO2004096993A2 Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences and methods for propagating virus
11/11/2004	WO2004096992A2 Lactobacillus acidophilus nucleic acid sequences encoding cell surface protein homologues and uses therefore
11/11/2004	WO2004096991A2 Bcl2l12 polypeptide activators and inhibitors
11/11/2004	WO2004096990A2 Pathophysiology associated with a single gene (mass1) mutation underlying the robust audiogenic seizure phenotype in frings mice
11/11/2004	WO2004096989A2 Single chain antigen-binding polypeptides for polymer conjugation
11/11/2004	WO2004096988A2 Discovery of biocatalysts and biocatalytic activities using nuclear magnetic resonance
11/11/2004	WO2004096987A2 A forward mutation assay based on 5-fluorouracil resistance
11/11/2004	WO2004096986A2 Method for quantitative detection of nucleic acid molecules
11/11/2004	WO2004096985A2 Methods for assessing biologic diversity
11/11/2004	WO2004096984A2 Preservation of rna in a biological sample
11/11/2004	WO2004096981A2 Albinism and vitligo
11/11/2004	WO2004096980A2 Novel polynucleotides encoding soluble polypeptides and methods using same
11/11/2004	WO2004096979A2 Methods and systems for annotating biomolecular sequences
11/11/2004	WO2004096978A2 Production of high mannose proteins in plant culture
11/11/2004	WO2004096976A2 Spex compositions and methods of use
11/11/2004	WO2004087881A3 Process for preparing reverse transcriptase inhibitors
11/11/2004	WO2004083391A3 Targeted and regional cellular ablation in zebrafish
11/11/2004	WO2004072236A3 Methods and compositions for 3-d sodium dodecyl sulfate-polyacrylamide cube gel electrophoresis
11/11/2004	WO2004063349A3 Lysozyme transgenic ungulates
11/11/2004	WO2004009799A3 Ion channel receptor and uses thereof
11/11/2004	US20040224398 TIMP3 as VEGF inhibitor
11/11/2004	CA2524165A1 Selective testicular 11.beta.-hsd inhibitors and methods of use thereof
11/11/2004	CA2523539A1 Production of high mannose proteins in plant culture
11/11/2004	CA2523537A1 Pathophysiology associated with a single gene (mass1) mutation underlying the robust audiogenic seizure phenotype in frings mice
11/11/2004	CA2523517A1 Bcl2l12 polypeptide activators and inhibitors
11/11/2004	CA2523501A1 Preservation of rna in a biological sample
11/11/2004	CA2523442A1 Molecular detection systems utilizing reiterative oligonucleotide synthesis
11/11/2004	CA2523323A1 Genes upregulated in a tomato plant having an increased anthocyanin content phenotype
11/11/2004	CA2523319A1 Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences and methods for propagating virus
11/11/2004	CA2523025A1 Spex compositions and methods of use
11/11/2004	CA2522925A1 Transgenic expression of a phytochrome a gene
11/11/2004	CA2522154A1 Recombinant plant dicer
11/11/2004	CA2521520A1 Multiply-primed amplification of nucleic acid sequences
11/11/2004	CA2521162A1 Single chain antigen-binding polypeptides for polymer conjugation
11/10/2004	EP1474535A2 Methods and compositions for treating aids and hiv-related disorders using 1414, 1481, 1553, 34021, 1720, 1683, 1552, 1682, 1675, 12825, 9952, 5816, 10002, 1611, 1371, 14324, 126, 270, 312, 167, 326, 18926, 6747, 1793, 1784, or 2045 molecules.
11/09/2004	US6816790 Method and apparatus for determining gene expression levels
11/05/2004	CA2464979A1 Embryogenic culture initiation of douglas fir by maltose
11/04/2004	WO2004094673A2 Methods for monitoring drug activities in vivo
11/04/2004	WO2004094623A2 Cell adhesion and extracellular matrix proteins
11/04/2004	WO2004094622A2 Extracellular messengers
11/04/2004	WO2004094621A2 Polynucleotide encoding a novel trp channel family member, ltrpc3, and splice variants thereof
11/04/2004	WO2004094620A2 Truncated baff receptors
11/04/2004	WO2004094617A2 Sensin polypeptides, encoding nucleic acids, mutations, and methods of their identification and use
11/04/2004	WO2004094616A2 Silencing transcription by methylation
11/04/2004	WO2004094614A2 Stabilized aptamers to platelet derived growth factor and their use as oncology therapeutics
11/04/2004	WO2004094613A2 Polyvalent protein complex
11/04/2004	WO2004094611A2 Reprogramming nuclear function with somatic cell cytoplasm
11/04/2004	WO2004094610A2 Wnt as a factor for cardiac myogenesis
11/04/2004	WO2004094609A2 Methods for characterizing signaling pathways and compounds that interact therewith
11/04/2004	WO2004094608A2 Human procolipase like nucleic acids and polypeptides and their methods of use threof
11/04/2004	WO2004094607A2 Methods of therapy and diagnosis using targeting of cells that express a human transporter-like protein
11/04/2004	WO2004094606A2 COMPOSITIONS AND METHODS FOR siRNA INHIBITION OF ANGIOPOIETIN 1 AND 2 AND THEIR RECEPTOR TIE2
11/04/2004	WO2004094605A2 Methods and compositions for inhibiting stat signaling pathways
11/04/2004	WO2004094604A2 Splice variants of human voltage-gated calcium channel alpha2delta-2 subunit designated-alpha2delta2-a and alpha2delta2-b

1 ... 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 ... 100